Filing Details
- Accession Number:
- 0001127602-23-020422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-06 17:02:49
- Reporting Period:
- 2023-07-01
- Accepted Time:
- 2023-07-06 17:02:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1830214 | Ginkgo Bioworks Holdings Inc. | DNA | Biological Products, (No Disgnostic Substances) (2836) | 872652913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1873507 | E. Mark Dmytruk | C/O Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue Boston MA 02210 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-07-01 | 65,282 | $0.00 | 482,310 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-07-01 | 18,125 | $0.00 | 500,435 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-07-01 | 1,634 | $0.00 | 502,069 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-07-03 | 40,637 | $1.80 | 461,432 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Restricted Stock Units | Disposition | 2023-07-01 | 65,282 | $0.00 | 65,282 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2023-07-01 | 18,125 | $0.00 | 18,125 | $0.00 |
| Class A Common Stock | Class B Common Stock | Disposition | 2023-07-01 | 1,634 | $0.00 | 1,634 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,300,478 | No | 4 | M | Direct | ||
| 797,500 | No | 4 | M | Direct | ||
| 643,411 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.
- Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
- Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
- Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
- The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
- Includes shares of Class B Common Stock that are subject to vesting conditions.
Billionaire Hedge Funds
